DYR1055

N/A

Report date: 2025/04/28 10:12:59

NME

Base Information

Drug NameDYR1055

Drug Alias NameDYR1055DYR-1055

ClassificationSmall molecules

Mechanisms of ActionSerine/threonine-protein kinase B-raf inhibitorsCyclin-dependent kinase 8 inhibitorsPhosphatidylinositol 3 kinase alpha inhibitors +[8]

TargetsSerine/threonine-protein kinase B-rafCyclin-dependent kinase 8Phosphatidylinositol 3 kinase alpha +[8]

Therapy Area/IndicationsColorectal Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesThe University Of Arizona

China Registration ClassN/A

Develop Information

Active CompaniesThe University Of Arizona

Inactive CompaniesN/A

Active IndicationsColorectal Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A